ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Medroxyprogesterone Acetate Tablet shortage

To Be Discontinued  2 presentations · 1 manufacturers · first FDA posting 2026-08-31 · last update 2026-08-31

Manufacturers: Pfizer Inc.

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
PROVERA, Tablet, 10 mg (NDC 0009-0051-01)Pfizer Inc.To Be Discontinued
 —Discontinuation of the manufacture of the drug; Withdrawal from sale expected September 2026.Posted 08/31/2026
Updated 08/31/2026
Discontinued 08/31/2026
PROVERA, Tablet, 2.5 mg (NDC 0009-0065-01)Pfizer Inc.To Be Discontinued
 —Discontinuation of the manufacture of the drug; Withdrawal from sale expected early October 2026.Posted 08/31/2026
Updated 08/31/2026
Discontinued 08/31/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)